Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Popular

Donald Trump Calls For Soros To Be Imprisoned: 'He's A Bad Guy'

President Trump has advocated for the imprisonment of billionaire Democratic donor George Soros.

Tucker Carlson Asks OpenAI CEO Sam Altman If He Ordered Employee's Murder

During an interview with OpenAI CEO Sam Altman, Tucker Carlson suggested Altman may have played a role in the death of former employee Suchir Balaji.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

Boeing workers reject their latest contract offer, extending strike at three Midwest plants

Another contract proposal has been rejected by Boeing workers who now have been from three Midwest plants where military aircraft and weapons are developed.

The Next Evolution in Public Treasuries - Ad

MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.

Tesla Stock Climbs Nearly 7% In Monday Pre-Market: What's Going On?

Shares of Tesla Inc. (NASDAQ: TSLA) climbed over 5% during pre-market trading session on Monday after CEO Elon Musk purchased massive shares, according to a recent regulatory filing.

Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad

Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.

Von der Leyen proposes bolder EU sanctions against Israel over the war in Gaza

ANTWERP, Belgium (AP) — European Commission President Ursula von der Leyen broke Wednesday with her pro-Israel stance and announced plans to seek sanctions and a partial trade suspension against Israel over .

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Trump to sign proclamation imposing $100K fee for H-1B visa applications, White House official says

WASHINGTON (AP) — President Donald Trump is preparing to sign a proclamation that will require a $100,000 application fee for H-1B visa applications among other changes to the program for highly skilled foreign workers that has come under scrutiny by the administration, according to a White House official.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

European Central Bank expected to keep rates on hold as economy weathers Trump's tariffs

FRANKFURT, Germany (AP) — Inflation is back under control, and the European economy is weathering Trump's tariff onslaught better than expected. Those are reasons the European Central Bank is expected to keep its benchmark interest rate unchanged Thursday.

The First Public Cash-Flowing Digital Treasury - Ad

Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.

Family says a man who died after going on a Universal roller coaster never let wheelchair stop him

ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.

Qatar denounces Israel before major summit on Israel's attack in Doha targeting Hamas leaders

DUBAI, United Arab Emirates (AP) — Qatar's prime minister denounced Israel on Sunday as foreign ministers from Arab and Muslim nations met to discuss a possible unified targeting the leadership of the militant group Hamas.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Will electric tractors gain traction? At a pilot event for farmers, researchers see possibilities

EAST LANSING, Mich. (AP) — In the soft dirt of an indoor horseback riding ring last month, a group of farmers got ready to test drive a new piece of equipment: an electric tractor.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Lithuanian prosecutors allege Russia-linked network planned arson attacks in Europe

VILNIUS, Lithuania (AP) — Lithuanian prosecutors said they uncovered a who are alleged to have planned and organized arson attacks in various European countries.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

UK inflation remains nearly double target ahead of expected interest rate hold

LONDON (AP) — Inflation in the U.K. held steady at 3.8% in the year to August, official figures showed Wednesday, a day before the Bank of England is widely expected to keep interest rates on hold.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

Digital Gold. Digital Oil. Digital Infrastructure. - Ad

Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.

ASML Invests Billions In Nvidia-Backed Mistral AI To Power Next Era Of Semiconductors

ASML partners with Mistral AI to enhance semiconductor manufacturing with AI, investing 1.3 billion euros for 11% stake.

Scott Bessent Meets BlackRock's Rick Rieder As Trump Eyes Fed Chair Replacement For Jerome Powell: Report

Scott Bessent is interviewing candidates to replace Jerome Powell as Federal Reserve Chair by May 2026, with BlackRock's Rick Rieder among those being considered.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service